GemPharmatech's Metabolic Disease Symposium
Hear from leading voices in metabolic disease research and development at GemPharmatech's annual symposium.
Metabolic disease represents one of the most active and exciting frontiers in drug development. This year, GemPharmatech's annual symposium brings together leading researchers and industry scientists to explore the mechanisms driving obesity, insulin resistance, and cardiometabolic dysfunction, with a focus on the pathways most relevant to next-generation therapeutic intervention.
Speakers:
Dr. Philipp E Scherer, Professor and Director, Touchstone Diabetes Center at UTSW Medical Center
Dr. Joe Brozinick, Associate VP, Cardiometabolic Research, Eli Lilly and Company
Dr. Kimberley D Bruce, Associate Professor of Medicine, University of Colorado Anschutz
Dr. John A. Hangasky III, Director, Discovery Research, Prolynx
Dr. Mark A. Rossi, Assistant Professor, Neuroscience and Cell Biology, Center for NeuroMetabolism Rutgers University
Dr. Qinghchun Tong, Professor, UTHealth Houston
Jian Luo, MD, Senior Director, Translational CVRM at Genentech, Inc.,
Preliminary Schedule:
8:30 am- 9:00 am: Welcome Session, Coffee & Pastries
9:00 am: Opening Remarks
9:15 am - 12:00 pm: Speaker Presentations
12:00 pm - 1:00 pm: Complimentary Lunch
1:00 - 4:00 pm: Speaking Presentations / Closing Remarks
Located at The Illumina Theater in The Alexandria at Torrey Pines:
Click the map below for directions. Illumina Theater is located inside the Alexandria, adjacent to the Farmer & The Seahorse restaurant. Signs will be posted at each entrance.
***Registration is subject to approval. This event is open to all scientists and researchers who can attend in-person on September 11th, 2026. This event is not open to sales representatives or service providers. Capacity is limited.